PT91719A - Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino - Google Patents

Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino

Info

Publication number
PT91719A
PT91719A PT91719A PT9171989A PT91719A PT 91719 A PT91719 A PT 91719A PT 91719 A PT91719 A PT 91719A PT 9171989 A PT9171989 A PT 9171989A PT 91719 A PT91719 A PT 91719A
Authority
PT
Portugal
Prior art keywords
derivatives
growth factor
bfgf
fobroblast
new human
Prior art date
Application number
PT91719A
Other languages
English (en)
Other versions
PT91719B (pt
Inventor
Paolo Sarmientos
Laura Bergonzoni
Antonella Isacchi
Gilles Cauet
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of PT91719A publication Critical patent/PT91719A/pt
Publication of PT91719B publication Critical patent/PT91719B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Eye Examination Apparatus (AREA)
PT91719A 1988-09-16 1989-09-14 Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino PT91719B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821795A GB8821795D0 (en) 1988-09-16 1988-09-16 New derivatives of human/bovine basic fibroplast growth factor

Publications (2)

Publication Number Publication Date
PT91719A true PT91719A (pt) 1990-03-30
PT91719B PT91719B (pt) 1995-05-31

Family

ID=10643728

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91719A PT91719B (pt) 1988-09-16 1989-09-14 Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino

Country Status (21)

Country Link
EP (2) EP0396664A1 (pt)
JP (1) JP2888575B2 (pt)
KR (1) KR900702027A (pt)
CN (1) CN1041181A (pt)
AT (1) ATE98693T1 (pt)
AU (1) AU620925B2 (pt)
CA (1) CA1340834C (pt)
DE (1) DE68911461T2 (pt)
DK (1) DK120290A (pt)
ES (1) ES2061855T3 (pt)
FI (1) FI902391A0 (pt)
GB (1) GB8821795D0 (pt)
HU (1) HUT53937A (pt)
IL (1) IL91615A0 (pt)
MY (1) MY104910A (pt)
NO (1) NO902176L (pt)
NZ (1) NZ230621A (pt)
PT (1) PT91719B (pt)
WO (1) WO1990002800A1 (pt)
YU (1) YU179489A (pt)
ZA (1) ZA897020B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143829A (en) * 1990-03-29 1992-09-01 California Biotechnology Inc. High level expression of basic fibroblast growth factor having a homogeneous n-terminus
US5478804A (en) * 1990-09-19 1995-12-26 The Salk Institute For Biological Studies Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
JP3135138B2 (ja) * 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
US6833354B1 (en) 1990-12-19 2004-12-21 Kaken Pharmaceutical Co., Ltd. Agent for the treatment of bone diseases
DE69205466T2 (de) * 1991-03-21 1996-05-30 Procter & Gamble Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten.
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
TW275068B (pt) * 1993-09-24 1996-05-01 American Cyanamid Co
AUPO247496A0 (en) 1996-09-23 1996-10-17 Resmed Limited Assisted ventilation to match patient respiratory need
US6214795B1 (en) * 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
FR2780416B1 (fr) * 1998-06-10 2002-12-20 Rhone Poulenc Nutrition Animal Procede industriel de production de proteines heterologues chez e. coli et souches utiles pour le procede
CA2381780C (en) * 1999-08-13 2015-03-10 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
ES2275361T3 (es) * 1999-12-22 2007-06-01 Ortho-Mcneil Pharmaceutical, Inc. Analogos del factor de crecimiento fibroblastico basico humano.
KR100812884B1 (ko) 2000-11-27 2008-03-11 가부시키가이샤 디나벡크 겐큐쇼 혈관신생 유전자를 코드하는 파라믹소바이러스 벡터 및 그 이용
US8772460B2 (en) * 2011-12-16 2014-07-08 Wisconsin Alumni Research Foundation Thermostable FGF-2 mutant having enhanced stability
CN106957359B (zh) * 2016-08-31 2020-04-24 黄志锋 Fgf1突变体及其医药应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81839A0 (en) * 1986-03-14 1987-10-20 Takeda Chemical Industries Ltd Polypeptide,dna and its use
WO1988005465A1 (en) * 1987-01-16 1988-07-28 Amgen Inc. Production of fibroblast growth factor
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
JP2879148B2 (ja) * 1987-07-07 1999-04-05 サイオス インコーポレイテッド 組換え繊維芽細胞成長因子
EP0326907A1 (en) * 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA and its use

Also Published As

Publication number Publication date
ZA897020B (en) 1990-08-29
EP0396664A1 (en) 1990-11-14
EP0363675A1 (en) 1990-04-18
HU895573D0 (en) 1990-11-28
JP2888575B2 (ja) 1999-05-10
EP0363675B1 (en) 1993-12-15
NZ230621A (en) 1992-06-25
WO1990002800A1 (en) 1990-03-22
ATE98693T1 (de) 1994-01-15
CN1041181A (zh) 1990-04-11
DK120290A (da) 1990-07-16
JPH03501855A (ja) 1991-04-25
IL91615A0 (en) 1990-04-29
MY104910A (en) 1994-06-30
DE68911461T2 (de) 1994-05-19
AU620925B2 (en) 1992-02-27
HUT53937A (en) 1990-12-28
GB8821795D0 (en) 1988-10-19
DK120290D0 (da) 1990-05-15
ES2061855T3 (es) 1994-12-16
YU179489A (en) 1991-10-31
FI902391A0 (fi) 1990-05-14
AU4317189A (en) 1990-04-02
CA1340834C (en) 1999-11-30
NO902176L (no) 1990-07-13
NO902176D0 (no) 1990-05-15
DE68911461D1 (de) 1994-01-27
KR900702027A (ko) 1990-12-05
PT91719B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
PT91719A (pt) Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino
PT955313E (pt) Nova proteina e processo para a sua producao
SG49097A1 (en) Nucleotide sequences coding for a protein with urease activity
DE69019609D1 (de) Proteine und deren Herstellung.
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
AU7180787A (en) Fibroblast growth factor
EP0237966A3 (en) Human basic fibroblast growth factor
ATE127844T1 (de) Dns und ihre verwendung.
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
EP0458959A4 (en) Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
ATE108458T1 (de) Immunglobulin-e-kompetitor.
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0315118A3 (en) Dna coding for endothelin and use thereof
KR920703789A (ko) 인체 염기성 fgf 뮤테인의 제조방법
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
EP0215110A4 (en) MANUFACTURING SOMATOMEDIN C.
DE3900770A1 (de) Verfahren zur herstellung von pdgf-a und pdgf-aa
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ATE107694T1 (de) Für a.nidulans-isopenicillin-n-synthetase codierende dns, deren verwendung und dafür codierende vektoren.
Tomkins Crack Growth--Present Status, Future Direction
FI964648A (fi) Menetelmä erytropoietiinianalogien valmistamiseksi ja niiden koodaavia DNA-sekvensseja
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941114

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960531